You are using an outdated browser. Please upgrade your browser to improve your experience.
Valgenesis VLMS 4.1 SP1 PS13

ValGenesis, Inc

ValGenesis, Inc

Valgenesis VLMS 4.1 SP1 PS13

by ValGenesis Inc
Valgenesis VLMS 4.1 SP1 PS13
Valgenesis VLMS 4.1 SP1 PS13
Valgenesis VLMS 4.1 SP1 PS13

What is it about?

ValGenesis, Inc. is the provider of the first enterprise application that manages the corporate validation lifecycle process. This solution is fully compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements. As the first fully paperless solution for electronic management of validation execution and approval, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association (PDA) New Innovative Technology Award in 2005

Valgenesis VLMS 4.1 SP1 PS13

App Details

Version
1.0
Rating
NA
Size
398Mb
Genre
Medical Productivity
Last updated
December 25, 2023
Release date
December 24, 2023
More info

App Screenshots

Valgenesis VLMS 4.1 SP1 PS13 screenshot-0
Valgenesis VLMS 4.1 SP1 PS13 screenshot-1
Valgenesis VLMS 4.1 SP1 PS13 screenshot-2
Valgenesis VLMS 4.1 SP1 PS13 screenshot-3
Valgenesis VLMS 4.1 SP1 PS13 screenshot-4
Valgenesis VLMS 4.1 SP1 PS13 screenshot-5

App Store Description

ValGenesis, Inc. is the provider of the first enterprise application that manages the corporate validation lifecycle process. This solution is fully compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements. As the first fully paperless solution for electronic management of validation execution and approval, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association (PDA) New Innovative Technology Award in 2005

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.